ZYUS Strengthens Leadership Team with Appointment of Vice President of Clinical ResearchPosted by On

SASKATOON, Saskatchewan–(BUSINESS WIRE)–ZYUS Life Sciences Corporation (the “Company”) (TSX-V: ZYUS), a Canadian-based life sciences company leading scientific research and global development of innovative cannabinoid-based pharmaceutical drug products, today announced that it has strengthened its leadership team with the appointment of Scott Livingstone to the role of Vice President of Clinical Research with its wholly owned subsidiary, ZYUS Life Sciences Inc. In this instrumental role, Mr.

Source link


Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.